PREGNANCY MULTIVITAMIN TABLET

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Vedd Meg Most

Termékjellemzők Termékjellemzők (SPC)
22-02-2023

Aktív összetevők:

BETA-CAROTENE; VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)

Beszerezhető a:

JAMP PHARMA CORPORATION

ATC-kód:

B03AE04

INN (nemzetközi neve):

IRON, MULTIVITAMINS AND MINERALS

Adagolás:

1.6MG; 3MG; 3.4MG; 20MG; 5MG; 10MG; 120MG; 13.8MG; 2MG; 0.15MG; 35MG; 50MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG

Gyógyszerészeti forma:

TABLET

Összetétel:

BETA-CAROTENE 1.6MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG

Az alkalmazás módja:

ORAL

db csomag:

15G/50G

Recept típusa:

Prescription

Termék összefoglaló:

Active ingredient group (AIG) number: 1747661005; AHFS:

Engedélyezési státusz:

APPROVED

Engedély dátuma:

2023-02-22

Termékjellemzők

                                _ Pregnancy Multivitamin Product Monograph_
_ Page 1 of 30_
PRODUCT MONOGRAPH
PR
PREGNANCY MULTIVITAMIN
Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use
Oral, Blue Tablet (evening) contains 1.1 mg of Folic Acid
Multivitamins and other Minerals Including Combinations
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Quebec
J4B 5H3, Canada
Control No.: 252149
Date of Revision:
February 22, 2023
_ Pregnancy Multivitamin Product Monograph_
_ Page 2 of 30_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
4
CONTRAINDICATIONS
.........................................................................................................................................
4
WARNINGS AND PRECAUTIONS
........................................................................................................................
4
ADVERSE REACTIONS
..........................................................................................................................................
6
DRUG INTERACTIONS
........................................................................................................................................
10
DOSAGE AND ADMINISTRATION
....................................................................................................................
15
OVERDOSAGE
......................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
...................................................................................................
17
STORAGE AND STABILITY
...........................................................................
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Dokumentumok más nyelveken

Termékjellemzők Termékjellemzők francia 22-02-2023